LPL Financial’s AMAG Pharmaceuticals AMAG Stock Holding History

LPL Financial’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-11,220	Closed	-$137K	–	3489
2019 Q4	$137K	Buy	+11,220	New	+$123K	﹤0.01%	3186
2018 Q2	–	Sell	-34,343	Closed	-$692K	–	3314
2018 Q1	$692K	Buy	+34,343	New	+$581K	﹤0.01%	1870
2015 Q4	–	Sell	-5,066	Closed	-$209K	–	3275
2015 Q3	$209K	Buy	5,066 +189	+4%	+$11.7K	﹤0.01%	2484
2015 Q2	$350K	Sell	4,877 -618	-11%	-$38.9K	﹤0.01%	2182
2015 Q1	$310K	Buy	+5,495	New	+$262K	﹤0.01%	2222

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

LPL Financial's AMAG Position: Q1 2020 in Review

LPL Financial sold out of AMAG Pharmaceuticals (AMAG) in Q1 2020, closing a stake of 11,220 shares — an estimated $137K sold.

LPL Financial first reported a position in AMAG in Q1 2015 and held it in 5 quarters. The position peaked at $692K in Q1 2018. 119 funds tracked by Wall St. Rank hold AMAG as of Q1 2020.

LPL Financial reported no remaining AMAG Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
LPL Financial sold 11,220 AMAG Pharmaceuticals shares in Q1 2020, an estimated $137K.
LPL Financial first reported a position in AMAG Pharmaceuticals in Q1 2015 and held it in 5 quarters.
LPL Financial's AMAG Pharmaceuticals position peaked at $692K in Q1 2018.
119 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2020.

Based on LPL Financial's 13F filing for Q1 2020, filed 14 May 2020.